Frankfurt - Delayed Quote EUR

Crinetics Pharmaceuticals, Inc. (6Z4.F)

Compare
38.60
+1.60
+(4.32%)
As of 8:10:16 AM GMT+1. Market Open.

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BEDROSIAN CAMILLE L Director Stock Award(Grant) Jun 7, 2024 9,400
BETZ STEPHEN F Officer Conversion of Exercise of derivative security Dec 16, 2024 71,358
HASSARD JAMES Officer Conversion of Exercise of derivative security Jul 5, 2024 29,259
KNIGHT JEFF E Chief Operating Officer Sale Nov 22, 2024 51,653
OKEY STEPHANIE S Director Stock Award(Grant) Jun 7, 2024 9,400
PIZZUTI DANA J Officer Conversion of Exercise of derivative security Jan 7, 2025 31,748
STRUTHERS RICHARD SCOTT Chief Executive Officer Sale Dec 2, 2024 --
VIVALDI COELHO ROGERIO Director Stock Award(Grant) Jun 7, 2024 14,400
WIERENGA WENDELL Director Stock Award(Grant) Jun 7, 2024 109,246
WILSON MARC Chief Financial Officer Conversion of Exercise of derivative security Sep 26, 2024 111,092